All Posts By

JAG Shaw Baker

Liability Rules And Ethical Standards For Artificial Intelligence

By | Artificial Intelligence, Current Affairs, Data & Privacy, Intellectual Property

EU told to lead the way on liability rules and ethical standards for Artificial Intelligence  Artificial Intelligence (AI) is constantly evolving and continues to roll into all facets of industry – from neural networks that connect recycling systems to sort recycling better to AI that makes self-driving cars safer or teaches machines to do more with less. As AI becomes more commercialised, it reveals the complexities around allocating risk and liability for the autonomous actions of AI. Existing EU laws governing liability are largely stable where human input is prevalent in the machine-decision making process. Consider a human instructing Siri…

Read More

How To Commercialise Life Sciences: Focus On The Basics

By | Biotech, Current Affairs, Guest Posts, Knowledge, Life Sciences

Life sciences research can translate into solutions, products and companies that provide significant benefit to both society and the economy. Today’s dynamic ecosystem presents tremendous opportunities for life sciences innovators given technological advances and rapidly changing market realities. Although the environment for commercialisation has changed dramatically over the last few decades, the basic principles of making it a success remain the same. A commercialisation plan enables innovators to set out and communicate their strategy to others. It should offer a clear and concise overview of the technology’s market potential and the planned route to commercialisation. It should also illustrate how…

Read More

The Power Of The Crowd At Millennial 20/20

By | Entrepreneurs, Events

Earlier this month, the Truman Old Brewery in East London was host to Millennial 20/20, a two day summit that looks at how companies of all scales are adapting to ensure ongoing engagement with the ever-changing consumer. JAG Shaw Baker Associates, Charlotte Courtney and Imran Bhatia, joined delegates from a of variety of sectors from fashion and beauty to finance, travel and food, each bringing a different perspective on how millennials are disrupting their businesses. The Power of the Crowd Day one included a session on the power of the crowd to shape the finance sector. Crowdfunding is demanding increasing levels of attention from companies looking to…

Read More

Elasmogen Inks Research Agreement To Develop New Class Of Therapeutics

By | Biotech, Client news, Knowledge, Life Sciences, Startups

Congratulations to our client Elasmogen! Elasmogen, a spin-out from Aberdeen University, alongside Canada based Feldan Therapeutics, have announced a research agreement with Amgen to develop and deliver novel intracellular biologics. The collaboration combines the unique capabilities of Feldan’s Shuttle platform and Elasmogen’s soloMER™ technology to develop the delivery system and binding domains for two undisclosed intracellular targets for Amgen. Elasmogen develops new medicines based on antibody-like molecules isolated from sharks, called VNARs (variable new-antigen receptors). VNARs are found in sharks as part of their immune system and have a similar protective role to antibodies present in the human body. The…

Read More

The Ins and Outs of Clinical Trials – Termination

By | Biotech, Knowledge, Life Sciences

Clinical trials are costly, involve numerous parties and depending on the phase of the trial, are a lengthy process. Although it’s unpleasant to talk about how to end a relationship before it’s even begun, a frank and complete discussion at the outset on how a contract is to be terminated amicably will benefit all parties involved. In this post, we’ll address a termination provision that a sponsor, typically a pharmaceutical company, can exercise and negotiate. Such provision is particular to a clinical trial agreement and which can be challenging to negotiate with other parties to the agreement, i.e. the institution…

Read More

Fake News And Its Impact On Tech Companies

By | Current Affairs, Data & Privacy, Fake News, Knowledge, Safe Harbours

Recently, there have been rising concerns that the public is being deceived by the unprecedented dissemination of fake news on the internet and on social media, in particular. The term fake news is a fluid concept but is generally understood to refer to fictitious reports designed to deliberately deceive readers in order to maximise internet traffic and profit. The term gained particular traction during the 2016 US presidential election following claims of harm to democratic process. Some people are taking the fight against fake news on themselves. The Fake News Challenge is a global grassroots effort of more than 100…

Read More

MyBuilder Acquired by HomeAdivsor

By | Client news, Current Affairs, Entrepreneurs, Investor and VC News, M&A, Startups

We ended March on a high note with some great M&A news for our client MyBuilder. The UK company was recently acquired by HomeAdvisor, an IAC company (NASDAQ: IAC) considered one of the largest home marketplaces in the world. JAG Shaw Baker represented the interests of MyBuilder and its investors, including the founder. This deal is a great example of JAG Shaw Baker’s expertise in creating the right balance between the interests of the selling parties to generate a sensible sell-side proposition to then deliver the sale to the buyer. The firm is proud to have been a part of this deal which was effectively done in a sharp two week period. According…

Read More

Parkinson’s UK Partners With Sheffield University To Create New Spin Out

By | Biotech, Client news, Life Sciences, Startups

Our client, Parkinson’s UK, has just inked a deal with Sheffield University to create a new £1million virtual biotech company, Keapstone Therapeutics. Even though charities and academia have entered into research partnerships before, the partnership between Parkinson’s UK and Sheffield is the first time a charity has approached researchers to launch a spin-out company with the agenda to advance a particular research programme. The Life Sciences team at JAG Shaw Baker has extensive experience with spin-out companies. The team was instrumental in structuring Keapstone Therapeutics in a way that aligned with Parkinson UK’s over-arching charitable objectives, the academic principles of Sheffield University and the requirements of a high-growth company. The…

Read More

Domain Names And Protecting Your Brand Online – Part 2

By | Domain names, Intellectual Property, Knowledge

In the last blog post on Domain Names And Protecting Your Brand Online, we looked at the importance of brand protection online. This post focuses on what a company can do to protect its brand against infringers and cybersquatters. Domain name infringement has strong ties with trade mark infringement. But the beauty of domain name disputes is that they don’t have to be dealt with in court. For example, disputes relating to infringing .uk domain names are submitted to Nominet. The costs are low in comparison with other legal disputes and can be as little as £200. And, disputes relating…

Read More

Domain Names And Protecting Your Brand Online

By | Data & Privacy, Intellectual Property, Knowledge

As a company grows and becomes more well-known, its reputation becomes more valuable. Filing trade marks to protect brand names and logos is now common place, but companies need to look at different ways of protecting its brand simply beyond having a robust trade mark portfolio. One way is to monitor how the brand is used online. It goes without saying that a company wouldn’t want another business using its brand name or logo in connection with its goods or services without authorisation. Companies are becoming more aware they need to take action where intellectual property (IP) rights are infringed. This includes stopping the infringement…

Read More

A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. more information

INFORMATION ABOUT OUR USE OF COOKIES Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience and also allows us to improve our website. By continuing to browse the website, you are agreeing to our use of cookies. A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. We use the following cookies: • Strictly necessary cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to return to a previous page. • Analytical/performance cookies. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily. The analytical/performance cookies are provided on our behalf by Google Inc. to aid with reporting of user behaviour, market research and improving website functionality. This user behaviour is analysed in order to improve this website. To see how this applies to Google Analytics, visit http://www.google.co.uk/intl/en/analytics/privacyoverview.html. You can stop tracking by Google Analytics by visiting https://tools.google.com/dlpage/gaoptout?hl=en-GB. COOKIE DURATION The strictly necessary session cookies are a temporary cookie which remains in the cookie file of your browser until you close the browser. The other cookies will remain in the cookie file of your browser after the closing of the browser, and will become active again when you reopen this website. The different cookies have different expiration dates. Following expiry of a cookie, a new version of that cookie will be downloaded when you next visit this website, unless you have withdrawn your consent in the meantime. You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our website. Contact If you have any queries regarding this cookie policy please contact us at info@jagshawbaker.com.

Close